Stryker Corporation’s opening quarter of 2025 was, to paraphrase one Wall Street analysts, a “top, middle and bottom beat” ...

Labs at 3 major centers design and test a dramatic new pain treatmeant that targets an entirely new pain receptor. Milestone event. A must-read.